Products

DenSeeMammo
Predilife
Oncology AI

See all 1 product →

About Predilife

Predilife is a pioneer in predictive medicine in France, offering unique digital prevention assessments that combine traditional health check-ups with predictive medicine. These assessments aim to anticipate diseases for better prevention, focusing on major cancers (breast, prostate, colon, lung, melanomas) and cardiovascular diseases. The company’s services are designed to be easily accessible through teleconsultation, leveraging the latest medical innovations, including proven medical techniques, Artificial Intelligence, and Big Data.

For physicians, Predilife provides predictive risk assessments for various pathologies, not diagnostic tests. These assessments, performed by healthcare professionals using Predilife’s Class I medical device software, estimate the risk of developing certain diseases. After an assessment, individuals receive personalized follow-up and recommendations to reduce the risk of serious pathologies. Predilife’s offerings include a predictive breast cancer assessment for women over 40, a multi-pathology predictive assessment for men and women over 40 covering several cancers and cardiovascular disease, and a general health assessment for all individuals.

Focus Areas

predictive medicine breast cancer risk assessment multi-pathology predictive tests artificial intelligence in healthcare big data in healthcare oncology cardiovascular disease personalized prevention

Business Intelligence

TechnologyAI-driven predictive analytics, Big Data modeling, telemedicine platform, secure patient portal, cloud-based certified hosting for health data, Class I medical device software (risk-estimation tools)

What Physicians Need to Know

Specialization
Predictive medicine, focusing on risk assessment for various serious diseases.
Key Offerings
Predictive assessments for breast cancer (MammoRisk), multi-pathology predictive assessments (including prostate, colon, lung, melanoma, and cardiovascular diseases), and general health assessments.
Target Audience
Women aged 40+ for breast cancer risk; women and men aged 40+ for multi-pathology assessments; and all individuals for general health assessments.
Accessibility
Digital prevention assessments accessible via teleconsultation, eliminating travel or scheduling constraints.
Cost-Effectiveness
Up to 5 times less expensive than traditional health assessments.
Pioneering Role
Pioneer of predictive medicine in France.
Regulatory Compliance
Medical devices registered with ANSM and MHRA (UK), compliant with European regulations (CE marking).
Physician Tip

Predilife offers digital predictive assessments that combine traditional health evaluations with predictive medicine, utilizing proven medical techniques, Artificial Intelligence, and Big Data. These assessments are designed to estimate the risk of developing various cancers (breast, prostate, colon, lung, melanoma) and cardiovascular diseases, rather than providing a diagnosis. Physicians can leverage these tools for personalized patient follow-up and recommendations based on individual risk profiles, facilitating proactive health management and prevention or delay of chronic diseases. The services are accessible via teleconsultation, making them convenient for patients. It is important to note that these are risk estimation tests, not diagnostic tests, and medical advice should always be sought.

The official website text does not explicitly mention integrations with other systems or platforms. It states that prevention assessments are performed by healthcare professionals using software that are Class I medical devices manufactured by Predilife.

Products by Predilife

1 product in the directory

DenSeeMammo
Predilife
Oncology AI

Videos

News, demos, and interviews about Predilife.

Loading videos...

Videos load interactively. If none appear, search YouTube for Predilife →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Predilife's predictive tests estimate the risk of developing various pathologies, allowing for personalized follow-up and recommendations to reduce risks.
The breast cancer predictive test is for women aged 40 and over, while the multi-pathology predictive test is for men and women aged 40 and over.
The multi-pathology predictive test estimates the risk of breast cancer, prostate cancer, lung cancer, colorectal cancer, melanoma, and cardiovascular disease.
Predilife combines proven medical techniques with artificial intelligence and big data to create its predictive health assessments.
Predilife accompanies healthcare professionals towards personalized and digital predictive medicine.
Predilife offers a predictive breast cancer assessment, a multi-pathology predictive assessment, and a general health assessment.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.